Haleon plc
Health
Performance
2.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

Haleon plc stock rating and score history

All changes in ratings, performance and outlook tracked over time.

05.09.2026
Fragile setup. Still failing to meet the key marks today.
05.09.2026
Still low-risk, but small tremors appearing.
03.09.2026
Losing steam. Not trending your way right now.
20.08.2025
Climbing out. Risks fading, but not out of the woods.
HLN
Low-poly 3D Haleon (HLN) stock icon with a stylized pill capsule, symbolizing healthcare and biotech.
9.37
+0.97%
2.1
Sell
Buy
Haleon plc

Haleon plc stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Haleon plc do? Business model and key facts

Get the full picture of Haleon plc: what it builds, where it operates, and how it makes money.

Haleon plc Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 24535

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

shop
Company facts
Brian James McNamara
CEO
24535
Employees worldwide
shop
Performance
3.11%
Last 12 months
23.73%
Last 5 years
shop
Growth
$14.84B
Revenue year
$2.19B
Net income
shop
Valuation
$40.87B
Market Cap
19.73
Price/Earnings Ratio

Stocks related to Haleon plc

Selected based on industry alignment and relative market positioning.

TEVA
Teva Pharmaceutical Industries Limited
40.09
+2.85%
2.6
Sell
Buy
Teva Pharmaceutical Industries Limited
MRK.DE
Merck KGaA
132.60
+2.12%
3.1
Sell
Buy
Merck KGaA
TAK
Takeda Pharmaceutical Company Limited
18.91
+0.00%
1.3
Sell
Buy
Takeda Pharmaceutical Company Limited
SDZNY
Sandoz Group AG
84.96
+1.86%
2.0
Sell
Buy
Sandoz Group AG
ZTS
Low-poly 3D Zoetis (ZTS) stock icon with a stylized paw print, symbolizing industrials.
71.32
-0.11%
4.8
Sell
Buy
Zoetis Inc.

Events and news impacting Haleon plc stock

Earnings, coporate decisions and industry developments that can affect the share price.

Haleon plc fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.